Once-yearly zoledronic acid 5 mg therapy for osteoporosis: a focus on a patient

Once-yearly zoledronic acid 5 mg therapy for osteoporosis: a focus on a patient

Show other versions (1)

Bibliographic Details
Main Author:	Irina Aleksandrovna Baranova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2011-09-01
Series:	Современная ревматология
Online Access:	http://mrj.ima-press.net/index.php/mrj/article/view/363

Similar Items

Once-yearly zoledronic acid 5 mg therapy for osteoporosis: a focus on a patient
by: Irina Aleksandrovna Baranova, et al.
Published: (2011-09-01)

Osteoporosis and venous thromboembolism
by: Irina Aleksandrovna Baranova, et al.
Published: (2011-02-01)

Treatment of postmenopausal osteoporosis, patient perspectives &ndash; focus on once yearly zoledronic acid
by: Raj Carmona, et al.
Published: (2009-07-01)

GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
by: Irina Aleksandrovna Baranova
Published: (2010-06-01)

Current approaches to the diagnosis and treatment of postmenopausal osteoporosis
by: Irina Aleksandrovna Baranova, et al.
Published: (2009-10-01)

Once-yearly zoledronic acid in hip fracture prevention
by: Oddom Demontiero, et al.
Published: (2009-03-01)

Management of osteoporosis in the aging male: Focus on zoledronic acid
by: Paul K Piper Jr, et al.
Published: (2009-06-01)

Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project
by: F. Bertoldo, et al.
Published: (2011-06-01)

Once-yearly zoledronic acid in the prevention of osteoporotic bone fractures in postmenopausal women
by: Irene Lambrinoudaki, et al.
Published: (2008-09-01)

Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis
by: Daisuke Watanabe, et al.
Published: (2021-04-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

Zoledronic acid in the treatment of osteoporosis: indications for use
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-06-01)

EFFECT OF ZOLEDRONIC ACID THERAPY ON FRACTURE RISK IN THE TREATMENT OF MEN WITH OSTEOPOROSIS
by: Steven Boonen, et al.
Published: (2012-12-01)

Single Dose Therapy of Zoledronic Acid for the Treatment of Transient Osteoporosis of Hip
by: Sanjay Agarwala, et al.
Published: (2019-06-01)

EFFECT OF 6-YEAR TREATMENT OF OSTEOPOROSIS WITH ZOLEDRONIC ACID 5MG (ACLASTA) COMPARED WITH THE 3-YEAR-TREATMENT, RESULTS OF EXTENDED HORIZON PFT STUDY
by: D M Black, et al.
Published: (2012-04-01)

Role of zoledronic acid in the prevention and treatment of osteoporosis
by: Räkel A, et al.
Published: (2011-03-01)

Zoledronic acid infusion for prevention and treatment of osteoporosis
by: John A Sunyecz
Published: (2010-10-01)

ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS
by: S Yu Vorotnikova, et al.
Published: (2016-12-01)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
by: Ege Can Serefoglu, et al.
Published: (2010-05-01)

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management
by: Luca Dalle Carbonare, et al.
Published: (2010-08-01)

EFFICACY AND TOLERABILITY OF GENERIC ZOLEDRONIC ACID 5 MG (REZOCLASTIN PS) IN THE TREATMENT OF OSTEOPOROSIS: A RETROSPECTIVE ANALYSIS OF CLINICAL EXPERIENCE WITH THE DRUG IN RUSSIA
by: L A Marchenkova, et al.
Published: (2014-12-01)

The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis
by: İlker Çorapçı, et al.
Published: (2004-03-01)

EFFECT OF ZOLEDRONIC AND IBANDRONIC ACIDS ON BONE METABOLISM IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS
by: O V Yakushevskaya, et al.
Published: (2012-08-01)

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients
by: Jun Xie, et al.
Published: (2019-12-01)

Comparative study of 99Tc-MDP and zoledronic acid in the treatment of osteoporosis
by: Ying Zhou, et al.
Published: (2020-08-01)

Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis
by: Johann D Ringe
Published: (2010-06-01)

Treatment of osteoporosis with annual iv zoledronic acid: effects on hip fracture
by: Rol, et al.
Published: (2009-01-01)

Retrospective Study of the Effects of Zoledronic Acid on Muscle Mass in Osteoporosis Patients
by: Huang CF, et al.
Published: (2021-08-01)

Potential protective effect of zoledronic acid when switching from long-term therapy of osteoporosis with denosumab
by: O. V. Yakushevskaya
Published: (2021-01-01)

Symptomatic Hypocalcemia Associated with Zoledronic Acid Treatment for Osteoporosis: A Case Report
by: Abdulmohsen H. Al Elq
Published: (2013-03-01)

Investigation of Intravenous Zoledronic Acid Therapy on Circulating Lymphocyte Subpopulation in Patients with Primary Osteoporosis: A Pilot Study
by: Min Cui, Ph. D, et al.
Published: (2021-01-01)

Study of Adverse Effect Profile of Parenteral Zoledronic Acid in Female Patients with Osteoporosis
by: Prem Kotian, et al.
Published: (2016-01-01)

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass
by: Ronald C Hamdy
Published: (2010-11-01)

The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis
by: Deepak Kumar Khajuria, et al.
Published: (2014-01-01)

Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
by: Paula Rackoff
Published: (2009-05-01)

IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
by: Lin H, et al.
Published: (2021-07-01)

Assessment of the Impact of Zoledronic Acid on Ovariectomized Osteoporosis Model Using Micro-CT Scanning.
by: Bo Shuai, et al.
Published: (2015-01-01)

Risk factors analysis in postmenopausal osteoporosis fragility fracture patients after treated with zoledronic acid
by: Ding Yue, et al.
Published: (2017-09-01)

Cost-Effectiveness of Zoledronic Acid to Prevent and Treat Postmenopausal Osteoporosis in Comparison with Routine Medical Treatment
by: Fateme Rostami Golmohamdi, et al.
Published: (2016-12-01)

Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment
by: I A Baranova, et al.
Published: (2008-03-01)